Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamsulosin for kidney pain in patients with renal pelvis stones
IRCT20241125063852N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of tamsulosin in nephrolithiasis, sponsored by Islamic Azad University. Primary endpoint: Changes in kidney pain at 12 hours. Started Jan 2025; status: completed.
02
Drugs
tamsulosin
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on IRCT20241125063852N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241125063852N1.